Skip to main content
Premium Trial:

Request an Annual Quote

UCSC Creates New Department for Bioinformatics, Microarray Research

NEW YORK, Feb. 18 (GenomeWeb News) - The University of California, Santa Cruz, has created a department of biomolecular engineering that will consolidate the school's bioinformatics programs and will include faculty and researchers in nanotechnology, protein engineering, and DNA microarrays, the school said yesterday.


David Deamer, a professor of chemistry and biochemistry, will serve as acting chairman of the department as the school recruits a permanent chairperson, the school said in a statement. The new department will be located in the Baskin School of Engineering.


David Haussler, a Howard Hughes Medical Institute investigator and director of UCSC's Center for Biomolecular Science and Engineering, and Kevin Karplus, director of the engineering school's undergraduate and graduate programs in bioinformatics, will join the department, which is expected to total 14 faculty members in disciplines that will encompass engineering, computer science, biology, and chemistry.


The school will establish undergraduate and graduate degree programs in biomolecular engineering focusing on engineering "of, with, or for biological molecules," the school said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.